• Chase A Cannon, Stephanie E McLaughlin, and Meena S Ramchandani.
• Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Public Health - Seattle & King County, 325 9th Avenue, Box 359777, Seattle, WA 98104, USA. Electronic address: ccannon5@uw.edu.
• Med. Clin. North Am. 2024 Mar 1; 108 (2): 403418403-418.

AbstractRates of sexually transmitted infections (STIs), especially cases of infectious and congenital syphilis, are increasing in the United States. Novel strategies for STI prevention are being explored and include doxycycline post-exposure prophylaxis and the potential utility of vaccines against gonorrhea. Self-collection of samples and point of care testing for STI are increasingly being employed in a variety of settings. Both can improve uptake of screening and lead to earlier detection and treatment of incident STI in target populations. Overcoming existing regulatory issues and optimizing implementation of current evidence-based strategies will be key to maximizing future STI prevention efforts. Here we provide an update for primary care providers on selected new strategies for STI prevention either currently available or under development for possible future use.Copyright © 2023 Elsevier Inc. All rights reserved.

13 keywords...

hide…